Nan Wu
Has grant
Assistant Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
PUMC Nova program
Open Date: 2016-01-01
Close Date: 2017-01-01
Articles (21)
Year:
2026
Study Design. Retrospective cohort study Objective. To establish the maximal outcome improvement (MOI) threshold for moderate-to-severe spinal deformity. Background. Interpretation of patient-reported outcome measures (PROMs) is often limited by ceiling effects and inadequate consideration of baseline status when determining clinically meaningful thresholds. Methods. One hundred and seven patients who underwent surgery for moderate-to-severe spinal deformity and completed ≥ 2-year follow-up were retrospectively included. The Scoliosis Research Society-22 revised (SRS-22r) was administered preoperatively and at ≥ 2-year follow-up to determine the MOI threshold using the anchor-based method. Anchor questions were derived from the SRS-22r satisfaction domain, with postoperative satisfaction defined as scores ≥ 4 on both questions. The MOI was calculated as the changes in SRS-22r scores relative to the total possible improvement. Receiver operating characteristic (ROC) curve analysis identified the optimal MOI threshold. Logistic regression analysis evaluated predictors associated with achieving the MOI threshold. Results. Significant radiographic and clinical improvements were obtained at ≥ 2-year follow-up. Dissatisfied patients had lower postoperative SRS-22r satisfaction (3.1±0.4 vs. 4.5±0.4, P <0.001) and subtotal scores (3.7±0.4 vs. 4.0±0.3, P <0.001). The determined MOI threshold for the SRS-22r score was 43.5%. Adolescents demonstrated a significantly higher mean MOI percentage than adults (50.3% vs. 42.8%, P =0.001), although the proportion achieving the MOI threshold was comparable between groups (73.4% vs. 62.8%, P =0.242). Male sex (OR=0.8, P =0.022) and surgical complications (OR=0.7, P <0.001) significantly decreased the likelihood of achieving the MOI threshold. Conversely, preoperative neurological deficits were associated with increased odds of meeting this threshold (OR=1.6, P =0.041). Conclusions. The MOI threshold for the SRS-22r in moderate-to-severe spinal deformity was 43.5%. Male sex and perioperative complications were negative predictors, while preoperative neurological deficits increased the probability of achieving clinically meaningful improvement.
Year:
2026
Chromoanagenesis is a catastrophic genomic phenomenon involving sudden, extensive rearrangements within one or a few cell cycles. In osteosarcoma, the most prevalent malignant bone tumor in children and adolescents, these events dramatically alter the genomic landscape, frequently disrupting key tumor suppressor genes like TP53 and RB1, amplifying oncogene expression, and propelling tumor progression and evolution. This review elucidates how key chromoanagenic mechanisms, such as chromothripsis and chromoanasynthesis, arise from replication stress and impaired DNA repair pathways, ultimately contributing to genomic instability in osteosarcoma. Chromothripsis features prominently in osteosarcoma, occurring in up to 62% of tumor regions and driving intratumoral heterogeneity through persistent genomic crises. Next-generation sequencing, optical genome mapping, and emerging technologies like single-cell sequencing empower researchers to detect and characterize these complex structural variants, demonstrating how a single catastrophic event can profoundly influence osteosarcoma progression over time. While targeted therapies for osteosarcoma have proven elusive, innovative strategies harnessing comprehensive genomic profiling and patient-derived preclinical models hold promise for uncovering tumor-specific vulnerabilities tied to chromoanagenesis. Ultimately, unraveling how these rapid, large-scale rearrangements fuel osteosarcoma’s aggressive nature will not only refine disease classification and prognosis but also pave the way for novel therapeutic approaches to enhance patient outcomes.
Year:
2025
Background: Osteogenesis imperfecta (OI) is marked by clinical and genetic heterogeneity, and the genotype–phenotype correlation remains not very clear. We conducted a clinical and genetic study in a Chinese OI cohort to determine the spectra of phenotypes and pathogenic variants. Methods: In this study, 298 Chinese families were recruited from 2019 to 2024. Clinical phenotypes including fractures, short stature, skeletal deformities, blue sclera, dentinogenesis imperfecta, and hearing loss were recorded and analyzed. Next-generation sequencing combined with PCR-based techniques was used to detect candidate pathogenic variants. Variant pathogenicity was evaluated via conservation analysis, bioinformatics analysis, and functional studies at the cellular level. In this OI cohort, the spectra of pathogenic variants, clinical phenotypes, and genotype–phenotype correlations were analyzed. Results: Our OI cohort included 71 type I (23.83%), 122 type III (40.94%), 90 type IV (30.20%), and 15 type V (5.03%) probands. The cohort consisted of 196 children (65.77%) and 102 adults (34.23%). For the first time, phenotypic differences between different age groups were confirmed. In total, we identified 231 variants, including 47 novel pathogenic variants. Notable variants include two atypical splicing variants, one small deletion, two small duplications, one gross deletion, and one gross duplication. New genotype–phenotype correlations were observed: patients with SERPINF1 variants had the highest fracture frequency, followed by those with WNT1 variants, compared to patients with other gene variants. Conclusions: We performed the clinical and genetic analysis in a large Chinese OI cohort. The expanded spectra of genetic variants and clinical phenotypes were constructed by identifying 47 novel pathogenic variants and summarizing the skeletal and extra-skeletal manifestations. The current paper will provide important evidence for the precise diagnosis of the disease.
Year:
2025
Background Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) is characterised by aplasia of the uterus, cervix and upper part of the vagina. The genetic aetiology remains incompletely understood. Methods We performed gene-level and gene set-level burden analyses based on exome sequencing/genome sequencing data from 727 probands with MRKHS and 2504 female control individuals. Single-cell RNA sequencing (scRNA-seq) was performed on human and mouse embryonic metanephros at different developmental stages. Genetic and transcriptomic data were integrated to prioritise suboptimal genetic signals, identify relevant cell types and determine key developmental stages. Potential digenic inheritance was assessed and prioritised using coexpression patterns from scRNA-seq data. Results We identified known MRKHS genes ( PAX8 , BMP7 , GREB1L ) and novel candidates ( PAN2 , AGPAT2 ) with exome-wide significance. Enriched biological processes included cell apoptosis and mesenchymal-to-epithelial transition. In human embryos, MRKHS-associated genes were enriched in the uterine epithelium at eight gestational weeks (w8) and Wolffian duct epithelium at w11, supporting the biological relevance of burden signals. We detected 992 digenic combinations in MRKHS, with three achieving exome-wide significance ( CPSF3L/CYP2A7 , AICDA/NOS1 , EVC2/KANK1 ). Conclusion Our study reveals both established and novel genetic contributors to MRKHS, links them to specific embryonic cell types and stages, and highlights potential digenic inheritance patterns. Integrating genetic burden and single-cell transcriptomic data provides new insights into the complex molecular mechanisms underlying MRKHS.
Year:
2025
Background: The smallest worthwhile effect (SWE) enables patients to evaluate the expected value of a treatment by weighing its benefits, risks, and costs. It has emerged as an alternative to the minimal clinically important difference (MCID) for interpreting patient-reported outcome measures (PROMs). The purposes of this study were to determine the SWE estimates and MCID thresholds in patients undergoing surgery for adult idiopathic scoliosis (AdIS) and to verify whether meeting or exceeding the SWE estimates correlates with satisfaction at a minimum of 2 years postoperatively. Methods: Patients with postoperative satisfaction measured at a minimum of 2 years were prospectively recruited between July 2017 and August 2022. The Scoliosis Research Society-22 revised (SRS-22r) questionnaire was preoperatively administered to estimate the SWE thresholds using the benefit-harm trade-off method. The baseline SRS-22r and the SRS-30 at a minimum of 2 years postoperatively were recorded to determine the MCID estimates using the anchor-based approach, with questions 24 to 30 of the SRS-30 used as anchors. A construct validity assessment was performed to evaluate the association between meeting or exceeding the 50th percentile of the SWE (SWE50) threshold and postoperative satisfaction (defined as a score of ≥4 on both SRS-22r satisfaction questions). Race and ethnicity data were collected from the medical records. Results: A total of 119 Asian participants (19 male and 100 female) with a mean age of 26.5 ± 7.2 years were included. The absolute SWE50 estimates for the SRS-22r were 0.8 (interquartile range [IQR], 0.6 to 1.2) for self-image, 0.0 (IQR, 0.0 to 0.2) for function, 0.0 (IQR, 0.0 to 0.6) for pain, 0.4 (IQR, 0.0 to 0.6) for mental health, and 0.4 (IQR, 0.2 to 0.6) for the total score. The MCID thresholds for the corresponding domains or total score were 0.7, 0.1, 0.1, 0.3, and 0.3, respectively. Achieving or exceeding the absolute SWE50 threshold for the total score (p < 0.001) or the self-image (chi-square, 11.3; p < 0.001), function (chi-square, 6.3; p = 0.012), or pain (chi-square, 5.7; p = 0.017) domain was significantly correlated with postoperative satisfaction at a minimum of 2 years. Conclusions: The SWE could serve as an effective alternative to the MCID for interpreting PROMs at a minimum of 2 years postoperatively in patients with AdIS. Level of Evidence: Prognostic Level II . See Instructions for Authors for a complete description of levels of evidence.
Year:
2025
Idiopathic scoliosis (IS) is the most common form of spinal deformity with unclear pathogenesis. In this study, we first reanalyzed the loci associated with IS, drawing upon previous studies. Subsequently, we mapped these loci to candidate genes using either location-based or function-based strategies. To further substantiate our findings, we verified the enrichment of variants within these candidate genes across several large IS cohorts encompassing Chinese, East Asian, and European populations. Consequently, we identified variants in the EPHA4 gene as compelling candidates for IS. To confirm their pathogenicity, we generated zebrafish mutants of epha4a . Remarkably, the zebrafish epha4a mutants exhibited pronounced scoliosis during later stages of development, effectively recapitulating the IS phenotype. We observed that the epha4a mutants displayed defects in left-right coordination during locomotion, which arose from disorganized neural activation in these mutants. Our subsequent experiments indicated that the disruption of the central pattern generator (CPG) network, characterized by abnormal axon guidance of spinal cord interneurons, contributed to the disorganization observed in the mutants. Moreover, when knocked down efnb3b , the ligand for Epha4a, we observed similar CPG defects and disrupted left-right locomotion. These findings suggested that ephrin B3-Epha4 signaling is vital for the proper functioning of CPGs, and defects in this pathway could lead to scoliosis in zebrafish. Furthermore, we identified two cases of IS in NGEF , a downstream molecule in the EPHA4 pathway. Collectively, our data provide compelling evidence that neural patterning impairments and disruptions in CPGs may underlie the pathogenesis of IS.
Year:
2025
Background State-of-the-art (SOTA) large language models (LLMs) are poised to revolutionize clinical medicine by transforming diagnostic, therapeutic, and interdisciplinary reasoning. Despite their promising capabilities, rigorous benchmarking of these models is essential to address concerns about their clinical proficiency and safety, particularly in high-risk environments. Methods This study implemented a multi-disciplinary, randomized, single-blind evaluation framework involving 27 experienced specialty clinicians with an average of 25.9 years of practice. The assessment covered 685 simulated and real clinical cases across 13 subspecialties, including both common and rare conditions. Evaluators rated LLM responses on medical strength (0–10 scale, where > 9.5 signified leading expert proficiency) and hallucination severity (0–5 scale for fabricated or misleading medical elements). Seven SOTA LLMs were tested, including top-ranked models from the ARENA leaderboard, with statistical analyses applied to adjust for confounders such as response length. Findings The evaluation revealed clinical plausibility in general-purpose LLMs, with Gemini 2.0 Flash leading raw scores and DeepSeek R1 excelling in adjusted analyses. Top models demonstrated proficiency comparable to a physician of 6 years post qualification experience (score ∼6.0), yet significant risks were noted. Instances of incompetence (scores ≤4) were detected across specialties, and 40 hallucination instances involving fabricated conditions, medications, and classification errors. These findings underscore the importance of implementing stringent safeguards to mitigate potential adverse outcomes in clinical applications. Interpretation While SOTA LLMs show substantial promise in enhancing clinical reasoning and decision-making, their unguarded application in medicine could present serious risks, such as misinformation and diagnostic errors. Human expert oversight remains crucial, particularly given reported incompetence and hallucination risks. Larger, multi-center studies are warranted to evaluate their real-world performance and track their evolution before broader clinical adoption.
Year:
2025
Objectives B3GALT6 ‐related disorders are characterized by severe early‐onset spinal deformities requiring surgical corrections but are associated with increased risks of perioperative complications. This study reports the clinical experience and outcomes of selecting the substantially touched vertebra ( STV ) as the lowest instrumented vertebra ( LIV ) in spinal surgeries for patients with B3GALT6 ‐related disorders, a group of extremely rare skeletal and connective tissue disorders. Methods This retrospective study included patients who were molecularly diagnosed with B3GALT6 ‐related disorders and received spinal surgeries for (kypho)scoliosis between 2017 and June 2023. Their medical records were reviewed. We also conducted a systematic literature review to identify (kypho)scoliosis management in patients with B3GALT6 ‐related disorders. Results We identified a total of four patients. Patient 1 presented with severe kyphoscoliosis and segmentation defects and received a pedicle subtraction osteotomy with short fusion and dual growing rods from T3 to L3 . However, coronal imbalance was observed at the 18‐month follow‐up. Genetic testing revealed biallelic disease‐causing variants in B3GALT6 . A revision surgery was successfully performed, with the level of the LIV extended to the STV ( L4 ). The LIV was similarly extended to the STV in the index surgery for subsequent Patients 2 and 3 who received preoperative genetic testing results, and no complication has been observed. Patient 4 underwent preoperative Halo‐pelvic traction to minimize complications, followed by posterior spinal fusion. The curves were successfully reduced without complications. A systematic literature review identified 86 articles reporting (kypho) scoliosis management in 12 of the 63 patients with B3GALT6 ‐related disorders. Limited surgical experience has been reported, with an increased rate of complications, including death. Conclusions Selecting the STV as the LIV is recommended in spinal surgeries for patients with B3GALT6 ‐related disorders, considering the characteristic joint hypermobility associated with the condition. Additionally, preoperative Halo‐pelvic traction may also be safe and effective. Furthermore, preoperative molecular diagnosis is essential for enabling precision medicine and minimizing complications.
Year:
2025
Idiopathic scoliosis (IS) is the most common form of spinal deformity with unclear pathogenesis. In this study, we firstly reanalyzed the loci associated with IS, drawing upon previous studies. Subsequently, we mapped these loci to candidate genes using either location-based or function-based strategies. To further substantiate our findings, we verified the enrichment of variants within these candidate genes across several large IS cohorts encompassing Chinese, East Asian, and European populations. Consequently, we identified variants in the EPHA4 gene as compelling candidates for IS. To confirm their pathogenicity, we generated zebrafish mutants of epha4a. Remarkably, the zebrafish epha4a mutants exhibited pronounced scoliosis during later stages of development, effectively recapitulating the IS phenotype. We observed that the epha4a mutants displayed defects in left-right coordination during locomotion, which arose from disorganized neural activation in these mutants. Our subsequent experiments indicated that the disruption of the central pattern generator (CPG) network, characterized by abnormal axon guidance of spinal cord interneurons, contributed to the disorganization observed in the mutants. Moreover, when knocked down efnb3b, the ligand for Epha4a, we observed similar CPG defects and disrupted left-right locomotion. These findings strongly suggested that ephrin B3-Epha4 signaling is vital for the proper functioning of CPGs, and defects in this pathway could lead to scoliosis in zebrafish. Furthermore, we identified two cases of IS in NGEF, a downstream molecule in the EPHA4 pathway. Collectively, our data provide compelling evidence that neural patterning impairments and disruptions in CPGs may underlie the pathogenesis of IS.
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (7)
Carol Wise
Director, Division of Molecular Genetics
Texas Scottish Rite Hospital for Children
Ying S. Zou
Johns Hopkins University
Wanlu Liu
PRINCIPAL INVESTIGATOR
Zhejiang University
Chikashi Terao
RIKEN
Michael To
Clinical Associate Professor
The University of Hong Kong
Sen Zhao
Baylor College of Medicine
James R. Lupski
-
Make your next move.
Prepare your application
Review drafts before you send them.